Lori J. Braender
At a glance: Lori J. Braender is General Counsel at Aquestive Therapeutics (AQST). Their latest SEC Form 4, filed Mar 11, 2026, reported a sale of $167K. On file: 0 purchase lines ($0) and 1 sale line ($167K).
Disclosed holdings: about $1.6M of AQST stock: 442,879 shares reported on their latest Form 4 (filed Mar 11, 2026), valued at the Nov 20, 2026 close of $3.53. This counts only AQST shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
General Counsel at Aquestive Therapeutics, Inc. (AQST)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Lori J. Braender's InsiderPrint
3 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $22K a trade.
- Bump outward: a purchase (2)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Douglas SchirleCFO · GSIT · 100% match
- Anthony DrabekDirector · NRIM · 100% match
- James MulatoPres Astronics Test Systems · ATRO · 100% match
- Percy C. Tomlinson Jr.Director · WINA · 100% match
- Glen Nickolas KuntzSvp, Mine Development · IE · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow Lori J. Braender
Get one email when Lori J. Braender files a new purchase or sale. Free.
At most one email a day about Lori J. Braender, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.